| P2093 | author name string | Pekka Nieminen | |
| | Matti Hakama | |
| | Ahti Anttila | |
| | Nea Malila | |
| | Jussi Tarkkanen | |
| | Maarit Leinonen | |
| | Laura Kotaniemi-Talonen | |
| | Pekka Laurila | |
| P2860 | cites work | Alternative technologies in cervical cancer screening: a randomised evaluation trial | Q33260497 |
| | Human papillomavirus and Papanicolaou tests to screen for cervical cancer | Q34702284 |
| | HPV screening for cervical cancer in rural India | Q34973414 |
| | Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer | Q35993801 |
| | Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting | Q36615447 |
| | Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study | Q37135912 |
| | HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. | Q51824401 |
| | The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. | Q51968734 |
| | Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. | Q53304855 |
| | Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland. | Q53320103 |
| | Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. | Q53322866 |
| | Screening for cancer of the uterine cervix. From the IARC Working Group on Cervical Cancer Screening and the UICC Project Group on the Evaluation of Screening Programmes for Cancer | Q68991260 |
| | Cervical cancer screening programme in Finland | Q73174175 |
| | Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3 | Q80629732 |
| | Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| | intraepithelial neoplasia | Q6058399 |
| | cervix uterine cancer | Q160105 |
| | adenocarcinoma | Q356033 |
| | adenocarcinoma in situ | Q18556562 |
| P304 | page(s) | c1804 | |
| P577 | publication date | 2010-04-27 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme | |
| P478 | volume | 340 | |